You are on Trendlyne United States. Click here to go to India website or make United States as your default

iRhythm Technologies Inc XNAS: IRTC

iRhythm Technologies Inc Live Share Price Today, Share Analysis and Chart

99.48 0.85 (0.86%)

77.90% Gain from 52W Low

217.9K XNAS Volume

XNAS 22 Apr, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for iRhythm Technologies Inc is on 02 May 2025 for the purpose of iRhythm Technologies Inc First Quarter Earnings Results for 2025 See details

iRhythm Technologies Inc Key Metrics

Select
All financials are in USD Million and price data in USD
VIEW MORE
Low Financial Strength
33.3 / 100
Expensive Valuation
5.0 / 100
Technically Neutral
51.8 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

iRhythm Technologies Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '261000250500750Actual RevenueAvg. Estimate
Hit

iRhythm Technologies Inc's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

Current EPS
-3.6
Avg. Estimate
-1.9
Low Estimate
-2.9
High Estimate
-1.3
Current EPS
Avg. Estimate
Hit

EPS is expected to grow by 48.2% in FY25

Consensus Recommendation

13 ANALYST Recommendations
BUY

Created with Highcharts 7.2.22Hold3Buy8Strong Buy

The consensus recommendation from 13 analysts for iRhythm Technologies Inc is BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

iRhythm Technologies Inc Stock Analysis

iRhythm Technologies Inc stock analysis with key metrics, changes, and trends.

iRhythm Technologies Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$591.84 M20.13%positive

Annual Revenue rose 20.13%, in the last year to $591.84 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit$113.29 M8.2%positive

Annual Net Profit rose 8.2% in the last year to $113.29 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Price to Earning Ratio-28.03-negative

Price to Earning Ratio is -28.03, which is negative.

Stock Price$99.48-11.25%negative

Stock Price fell 11.25% and underperformed its sector by 18.96% in the past year.

Quarterly Revenue$164.32 M24.01%positive

Quarterly Revenue rose 24.01% YoY to $164.32 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

Quarterly Net profit$1.33 M96.56%positive

Quarterly Net profit rose 96.56% YoY to $1.33 M. Its sector's average net profit growth YoY for the quarter was 32.9%.

Debt to Equity Ratio8.11-negative

Debt to Equity Ratio of 8.11 is higher than 1. This implies that company assets are financed through debt.

Return on Equity(ROE)-75.27 %-75.27%negative

Return on Equity(ROE) for the last financial year was -75.27%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding93.78 %2.39%positive

Mutual Fund Holding increased by 2.39% in the last quarter to 93.78.

Promoter Share Holding1.70 %0.38%positive

Promoter Share Holding increased by 0.38% in the most recent quarter to 1.7%.

Interest Coverage Ratio-7.79-negative

Interest Coverage Ratio is -7.79, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding114.79 %0.06%positive

Institutional Holding increased by 0.06% in the last quarter to 114.79.

VIEW LESS


Loading data..

iRhythm Technologies Inc - Company Profile

What does iRhythm Technologies Inc do?

iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

iRhythm Technologies Inc Management structure

All Gross Remunerations are in USD
Mr. Quentin S. Blackford
Director, President and Chief Executive Officer
9.34 M
2024
Gross Remuneration
Year
Mr. Chad Patterson
Chief Commercial Officer
3.64 M
2024
Gross Remuneration
Year
Dr. Minang Turakhia, M.D.,M.S.
Chief Medical Officer, Chief Scientific Officer and Executive Vice President, Product Innovation
3.32 M
2024
Gross Remuneration
Year
Mr. Patrick M. Murphy
Chief Business Officer and Chief Legal Officer
3 M
2024
Gross Remuneration
Year
Mr. Brice Bobzien
Chief Financial Officer
2.73 M
2024
Gross Remuneration
Year
Mr. Daniel G. Wilson
Chief Financial Officer
2.54 M
2024
Gross Remuneration
Year

iRhythm Technologies Inc Board of directors

All Gross Remunerations are in USD
Ms. Mojdeh Poul
Independent Director
-
2025
Gross Remuneration
Year

iRhythm Technologies Inc FAQ

How is iRhythm Technologies Inc today?
iRhythm Technologies Inc today is trading in the green, and is up by 0.86% at 99.48.
iRhythm Technologies Inc is currently trading up 0.86% on an intraday basis. In the past week the stock fell -3.60%. stock has been down -8.49% in the past quarter and fell -11.25% in the past year. You can view this in the overview section.